In
connection with the Quarterly Report of BioSante Pharmaceuticals, Inc.
(the
“Company”) on Form 10-Q for the quarterly period ended March 31, 2007 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Phillip B. Donenberg, Chief Financial Officer, Treasurer and Secretary
of the
Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my
knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date:
May
1, 2007
/s/
Phillip B. Donenberg
Phillip
B. Donenberg
Chief
Financial Officer, Treasurer and Secretary